All healthcare professionals who work in rheumatology had to start adapting to a new landscape of reporting and documentation on Jan. 1 of this year, when the Medicare Access and […]

An ARHP session on Monday will offer attendees the latest information on new medications, new indications, safety issues, and FDA action on biosimilars over the past year. The session, Pharma […]

The practicing rheumatologist needs a basic understanding of the scientific principles that underlie autoimmune and inflammatory disorders. However, as both basic and clinical science knowledge grows, incorporating science material into […]

Older adults, for whom mobility is critical to maintain independence, make up a significant percentage of the patients cared for by rheumatologists. Those who lose independence are less likely to […]

It is increasingly recognized that changes in chondrocyte phenotypes play an active role in the response of cartilage to injury and in the pathogenesis of osteoarthritis (OA). The symposium Chondrocytes: […]

A panel will update attendees Monday on various bone-related disease issues, including current and investigational medications for treatment of osteoporosis, pediatric bone disease and its progression into adulthood, and osteonecrosis […]

A session on Monday will explore the effect of rheumatoid arthritis (RA) disease activity on cardiovascular disease (CVD) outcomes in patients with RA. Joan M. Bathon, MD, Professor of Medicine […]

Recent research findings provide new information about how adiposity leads to a systemic inflammatory state and to metabolic derangement, the relationship between osteoarthritis (OA), metabolic signaling and adipokines, and metabolic […]

A pair of experts on Monday afternoon will update attendees with new information on the dysregulation of cell processes related to malignancy and inflammation and the development of novel targeted […]